Molecular diagnosis of human granulocytic anaplasmosis

Authors: Dumler, J Stephen; Brouqui, Philippe

Source: Expert Review of Molecular Diagnostics, Volume 4, Number 4, July 2004 , pp. 559-569(11)

Buy & download fulltext article:

Price: $73.00 plus tax (Refund Policy)

Abstract:

Human granulocytic anaplasmosis, formerly known as human granulocytic ehrlichiosis, is caused by the microorganism Anaplasma phagocytophilum that is transmitted by Ixodes tick bites. The disease state ranges from subclinical to fatal but may be difficult to differentiate from other febrile conditions without specific tests. Rapid and early diagnosis is important since the infection may be fatal and specific antibiotic therapy is required. The bacterium is an obligate intracellular pathogen of neutrophils. Thus, early diagnosis is best achieved by amplification of nucleic acids from the blood. An increasing number of potential gene targets for diagnostic assays have been described and the incipient release of an Anaplasma phagocytophilum genome sequence will not only help to better understand the disease but may facilitate improvements in diagnostic strategies.

Keywords: Anaplasmataceae; anaplasmosis; Ehrlichia; ehrlichiosis; molecular diagnosis; PCR; rickettsia; tick-borne infection; zoonosis

Document Type: Research article

DOI: http://dx.doi.org/10.1586/14737159.4.4.559

Publication date: 2004-07-01

More about this publication?

Expert Review of Molecular Diagnostics provides expert reviews on molecular diagnostic technologies and applied pharmacogenomics in clinical medicine. Coverage includes molecular diagnostics, biomarkers, diagnostic technologies, microarrays and biochips, proteomics, pharmacogenomics, pharmacogenetics and personalized medicine.
Editorial Board
Information for Authors
Submit a Paper
Subscribe to this Title
Information for Advertisers
Terms & Conditions
Information for Librarians
Free Trials
ingentaconnect is not responsible for the content or availability of external websites